Tags : Levena

Navrogen and Levena Collaborate to Develop ADCs for Humoral Immuno-Suppressed

Shots: Navrogen expands its collaboration with Levena to develop ADCs targeting humoral immuno-suppressed cancers The collaboration will deploy Levena’s linker and cytotoxic payload chemistry expertise with Navrogen’s cancer-targeting Abs discovered utilizing HIO platform technologies. Levena will also utilize its process development and GMP capabilities The expansion of collaboration allows Navrogen to advance ADCs toward clinical […]Read More